005690 — Pharmicell Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Pharmicell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25,849	36,244	25,953	14,019	11,201
Net Total Accounts Receivable
Net Total Receivables	10,290	9,603	11,979	7,811	16,750
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42,939	65,041	62,363	43,166	48,035
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16,948	19,476	36,838	40,722	42,568
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	69,744	94,333	112,694	92,519	99,264
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,508	24,943	28,546	7,763	7,646
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	12,639	30,462	32,982	12,122	12,825
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	57,105	63,871	79,712	80,397	86,439
Total Liabilities & Shareholders' Equity	69,744	94,333	112,694	92,519	99,264
Total Common Shares Outstanding